STOCK TITAN

Relief Therapeutics Holding SA - RLFTF STOCK NEWS

Welcome to our dedicated news page for Relief Therapeutics Holding SA (Ticker: RLFTF), a resource for investors and traders seeking the latest updates and insights on Relief Therapeutics Holding SA.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Relief Therapeutics Holding SA's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Relief Therapeutics Holding SA's position in the market.

Rhea-AI Summary
Relief Therapeutics announces over 400,000 outstanding ADRs, a key requirement for NASDAQ listing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.55%
Tags
none
-
Rhea-AI Summary
Relief Therapeutics announces over 400,000 outstanding ADRs, a key requirement for NASDAQ listing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary
RELIEF THERAPEUTICS to present at H.C. Wainwright Global Investment Conference on Sept. 13, 2023
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
22.68%
Tags
conferences
Rhea-AI Summary
RELIEF THERAPEUTICS to present at H.C. Wainwright Global Investment Conference on Sept. 13, 2023
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
43.45%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.89%
Tags
none
Rhea-AI Summary
Relief Therapeutics announces that its state-of-the-art laboratory in Balerna, Switzerland has been audited and approved by Swissmedic, the national authorization and supervisory authority for drugs and medical products. The laboratory meets Good Manufacturing Practice (GMP) standards and offers a comprehensive suite of analytical and development services. The lab is designed to meet forthcoming pharmaceutical challenges and is fully integrated with current R&D capabilities.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.7%
Tags
none
-
Rhea-AI Summary
Relief Therapeutics announces that its state-of-the-art laboratory in Balerna, Switzerland has been audited and approved by Swissmedic, the national authorization and supervisory authority for drugs and medical products. The laboratory meets Good Manufacturing Practice (GMP) standards and offers a comprehensive suite of analytical and development services. The lab is designed to meet forthcoming pharmaceutical challenges and is fully integrated with current R&D capabilities.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Rhea-AI Summary
Relief Therapeutics announces implementation timeline for reverse split of its ordinary shares
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
16.67%
Tags
none
Relief Therapeutics Holding SA

OTC:RLFTF

RLFTF Rankings

RLFTF Stock Data

17.72M
8.39M
0.57%
37.06%
Medicinal and Botanical Manufacturing
Manufacturing
Link
Switzerland
Geneve